Washington, DC
The inaugural Brain Trauma Blueprint (BTB) Action Summit held on October 18-19th 2022 at the Ronald Reagan Building and International Trade Center in Washington DC, will convene national stakeholder groups across government, academia, foundations, industry, and individuals with lived experience, to plan to execute the TBI Precision Research Roadmap, through collective public and private action.
Every year, millions of Americans, including veterans and active military, experience traumatic brain injuries and their devastating chronic effects, including suicide. Yet, in 2022, we still have no FDA-approved TBI diagnostics or treatments.
Through prior BTB State-of-the-Science Summits we worked with the research community to identify and publish consensus challenges and a path ahead. The resulting TBI Precision Research Roadmap maps out priorities for accelerating a first generation of precision diagnostics and targeted treatments for brain trauma.
Through the Action Summit, the TBI leadership community will discuss priorities and a path to foster collaboration across the broader stakeholder community to achieve solutions sooner for those suffering from trauma-related brain disorders.
The Brain Trauma Blueprint is a framework to advance precision diagnostics and therapeutics for brain trauma through a process of community stakeholder consensus roadmapping and collaborative execution. More information can be found here.
Cohen Veterans Bioscience is a non-profit 501(c)(3) biomedical research and technology organization dedicated to advancing brain health by fast-tracking precision diagnostics and tailored therapeutics.
Cohen Veterans Bioscience is a non-profit 501(c)(3) biomedical research and technology organization dedicated to advancing brain health by fast-tracking precision diagnostics and tailored therapeutics.
©2023 Cohen Veterans Bioscience Privacy Policy | Terms of Use
